FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.uv.ebm
Resource TypeEvidenceVariable
IdEvidenceVariable-179784.json
FHIR VersionR6

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: EvidenceVariable 179784

version: 3; Last updated: 2023-12-01 22:26:01+0000; Language: en

Profile: GroupAssignment

ArtifactPublicationStatus: Active

url: https://fevir.net/resources/EvidenceVariable/179784

identifier: FEvIR Object Identifier/179784

name: Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis

title: GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis

citeAs:

GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784.

status: Active

author: Brian S. Alper:

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication (Evidence Communication)group-assignment

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

Definitions

-Concept
*Defined in handling and category elements

handling: dichotomous variable

category

name: Therapeutic-dose anticoagulation with heparin

value: ExposureDefinition: Therapeutic-dose anticoagulation with heparin

category

name: Usual-care pharmacologic thromboprophylaxis

value: ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis


Source1

{
  "resourceType": "EvidenceVariable",
  "id": "179784",
  "meta": {
    "versionId": "3",
    "lastUpdated": "2023-12-01T22:26:01.820Z",
    "profile": [
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"
    ]
  },
  "language": "en",
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
            "code": "active",
            "display": "Active"
          }
        ]
      }
    }
  ],
  "url": "https://fevir.net/resources/EvidenceVariable/179784",
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "179784",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    }
  ],
  "name": "Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis",
  "title": "GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis",
  "citeAs": "GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784.",
  "status": "active",
  "author": [
    {
      "name": "Brian S. Alper"
    }
  ],
  "publisher": "Computable Publishing LLC",
  "contact": [
    {
      "telecom": [
        {
          "system": "email",
          "value": "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description": "Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19",
  "useContext": [
    {
      "code": {
        "system": "https://fevir.net/resources/CodeSystem/179423",
        "code": "evidence-communication",
        "display": "Evidence Communication"
      },
      "valueCodeableConcept": {
        "text": "group-assignment"
      }
    }
  ],
  "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "definition": {
    "concept": {
      "coding": [
        {
          "system": "https://fevir.net/resources/CodeSystem/179423",
          "code": "defined-in-handling-and-category",
          "display": "Defined in handling and category elements"
        }
      ]
    }
  },
  "handling": "dichotomous",
  "category": [
    {
      "name": "Therapeutic-dose anticoagulation with heparin",
      "valueReference": {
        "reference": "Group/179786",
        "type": "Group",
        "display": "ExposureDefinition: Therapeutic-dose anticoagulation with heparin"
      }
    },
    {
      "name": "Usual-care pharmacologic thromboprophylaxis",
      "valueReference": {
        "reference": "Group/179785",
        "type": "Group",
        "display": "ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis"
      }
    }
  ]
}